Showing results (621-630 of 722) with videos related to

Sort By:
Pageof 73
American Heart Journal|February 15, 2011
Prehospital triage in the ambulance reduces infarct size and improves clinical outcomeSonja Postma, Jan-Henk E Dambrink, Menko-Jan de Boer, et al.
European Heart Journal|May 14, 2004
Facilitation of primary coronary angioplasty by early start of a glycoprotein 2b/3a inhibitor: results of the ongoing tirofiban in myocardial infarction evaluation (On-TIME) trialArnoud W J van 't Hof, Nicolette Ernst, Menko-Jan de Boer, et al.
Circulation. Cardiovascular Interventions|March 4, 2025
Early Versus Delayed Invasive Management of Female Patients With Non-ST-Elevation Acute Coronary Syndrome: An Individual Patient Data Meta-AnalysisGregory B Mills, Christos P Kotanidis, Shamir Mehta, et al.
BMC Cardiovascular Disorders|June 13, 2021
Feasibility and safety of cangrelor in patients with suboptimal P2Y12 inhibition undergoing percutaneous coronary intervention: rationale of the Dutch Cangrelor RegistryA Selvarajah, A H Tavenier, W L Bor, et al.
The American Journal of Cardiology|November 12, 2021
Meta-Analysis Evaluating High-Sensitivity Cardiac Troponin T Kinetics after Coronary Artery Bypass Grafting in Relation to the Current Definitions of Myocardial InfarctionSamuel Heuts, Ellen J S Denessen, Jean H T Daemen, et al.
The Journal of Invasive Cardiology|July 12, 2012
Impact of preprocedural TIMI flow on myocardial perfusion, distal embolization and mortality in patients with ST-segment elevation myocardial infarction treated by primary angioplasty and glycoprotein IIb/IIIa inhibitorsMauro Maioli, Uwe Zeymer, Arnoud W J van 't Hof, et al.
Heart (British Cardiac Society)|October 22, 2010
High-dose tirofiban pretreatment reduces the need for bail-out study medication in patients with ST-segment elevation myocardial infarction: results of a subgroup analysis of the On-TIME 2 trialR S Hermanides, A A C M Heestermans, J M Ten Berg, et al.
Journal of the American College of Cardiology|September 15, 2004
Achieved platelet aggregation inhibition after different antiplatelet regimens during percutaneous coronary intervention for ST-segment elevation myocardial infarctionNicolette M S K J Ernst, Harry Suryapranata, Kor Miedema, et al.
Annals of Clinical Biochemistry|July 11, 2006
Predictors of elevated cardiac troponin T on admission in ST-segment elevation myocardial infarctionSaman Rasoul, Mark B Nienhuis, Jan Paul Ottervanger, et al.
European Heart Journal. Acute Cardiovascular Care|May 25, 2019
Impact of elevated HbA1c on long-term mortality in patients presenting with acute myocardial infarction in daily clinical practice: insights from a 'real world' prospective registry of the Zwolle Myocardial Infarction Study GroupRenicus S Hermanides, Mark W Kennedy, Elvin Kedhi, et al.
Pageof 73